Michael R. Freeman
ScholarGPS® ID: 49845614358782
Affiliation History
Field
Medicine
Discipline
Surgery
Top Specialties
Cancer | Prostate Cancer | Neoplasm | Growth Factor | Smooth Muscle | Proteomics | Cancer Cell | Androgen Receptor | Lipid | Lipid Raft | Cell Growth | Metastasis | Extracellular Vesicle | Epidermal Growth Factor | Proteome
Metrics Summary
Publication Count
256
Predicted Citations
18,528
Predicted h-index
75
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Nature, volume 630, issue 8017, pages 736-743 (2024). |
The effects of glycemic index on prostate cancer progression in a xenograft mouse model (journal article) Prostate Cancer and Prostatic Diseases, volume 27, issue 2, pages 348-354 (2024). |
Cellular Oncology (2024). |
Nature Reviews Urology, volume 21, issue 5, pages 274-289 (2024). |
Frontiers in Oncology, volume 13 (2023). |
Actionable Driver Events in Small Cell Lung Cancer (journal article) International Journal of Molecular Sciences, volume 25, issue 1, pages 105- (2023). |
International Journal of Molecular Sciences, volume 24, issue 18, pages 13673- (2023). |
Autonomous action and cooperativity between the ONECUT2 transcription factor and its 3′ untranslated region (journal article) Frontiers in Cell and Developmental Biology, volume 11 (2023). |
MP20-02 27 HYDROXYCHOLESTEROL AND DNA DAMAGE REPAIR: IMPLICATIONS IN PROSTATE CANCER (journal article) Journal of Urology, volume 209, issue Supplement 4 (2023). |
ONECUT2 regulates RANKL-dependent enterocyte and microfold cell differentiation in the small intestine; a multi-omics study (journal article) Nucleic Acids Research, volume 51, issue 3, pages 1277-1296 (2023). |
Targeting Glutamine Metabolism in Prostate Cancer (journal article) Frontiers in Bioscience-Elite, volume 15, issue 1, pages 2- (2023). |
European Urology Open Science, volume 40 (2022). |
Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis (journal article) Nature Communications, volume 13, issue 1 (2022). |
BoxCar and shotgun proteomic analyses reveal molecular networks regulated by UBR5 in prostate cancer (journal article) PROTEOMICS, volume 22, issue 4 (2022). |
Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity (journal article) Clinical Cancer Research, volume 28, issue 2, pages 414-424 (2022). |
Cancers, volume 13, issue 22, pages 5850- (2021). |
Prostate Cancer and Prostatic Diseases, volume 24, issue 3, pages 733-742 (2021). |
MP33-07 SERUM CHOLESTEROL-LOWERING IN A PROSTATE CANCER MODEL ENHANCES ANTITUMOR IMMUNITY BY DECREASING MTOR2 SIGNALING IN CD8+ LYMPHOCYTES (journal article) Journal of Urology, volume 206, issue Supplement 3 (2021). |
A morphological subset of circulating tumor cells in advanced prostate cancer reveals a potential biomarker for clinical outcomes. (journal article) Journal of Clinical Oncology, volume 39, issue 15_suppl, pages e17008-e17008 (2021). |
Antioxidant functions of DHHC3 suppress anti-cancer drug activities (journal article) Cellular and Molecular Life Sciences, volume 78, issue 5, pages 2341-2353 (2021). |